Additionally, we established the antitumor effect of SRE in combination with anti-PD-1 antibodies using a humanized PD-L1 MC38 CRC cell-bearing humanized PD-1 knockin mouse model. This evidence concerns the gene CD274 and colorectal carcinoma.